Microglia
Research has discovered dystrophic (defective development) human microglia. "These cells are characterized by abnormalities in their cytoplasmic structure, such as deramified, atrophic, fragmented or unusually tortuous processes, frequently bearing spheroidal or bulbous swellings." The incidence of dystrophic microglia increases with aging. Microglial degeneration and death have been reported in research on Prion disease, Schizophrenia and Alzheimer's disease, indicating that microglial deterioration might be involved in neurodegenerative diseases. A complication of this theory is the fact that it is difficult to distinguish between "activated" and "dystrophic" microglia in the human brain.
Microelectrode array
The first implantable arrays were microwire arrays developed in the 1950s. The first experiment involving the use of an array of planar electrodes to record from cultured cells was conducted in 1972 by C.A. Thomas, Jr. and his colleagues. The experimental setup used a 2 x 15 array of gold electrodes plated with platinum black, each spaced 100 µm apart from each other. Myocytes harvested from embryonic chicks were dissociated and cultured onto the MEAs, and signals up to 1 mV high in amplitude were recorded. MEAs were constructed and used to explore the electrophysiology of snail ganglia independently by Guenter Gross and his colleagues at the Center for Network Neuroscience in 1977 without prior knowledge of Thomas and his colleagues' work. In 1982, Gross observed spontaneous electrophysiological activity from dissociated spinal cord neurons, and found that activity was very dependent on temperature. Below about 30˚C signal amplitudes decrease rapidly to relatively small value at room temperature.